0001104659-20-002747.txt : 20200109 0001104659-20-002747.hdr.sgml : 20200109 20200109180126 ACCESSION NUMBER: 0001104659-20-002747 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200101 FILED AS OF DATE: 20200109 DATE AS OF CHANGE: 20200109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Herman Philip Karl CENTRAL INDEX KEY: 0001799303 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38650 FILM NUMBER: 20519077 MAIL ADDRESS: STREET 1: C/O Y-MABS THERAPEUTICS, INC. STREET 2: 230 PARK AVENUE, SUITE 3350 CITY: NEW YORK STATE: NY ZIP: 10169 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Y-mAbs Therapeutics, Inc. CENTRAL INDEX KEY: 0001722964 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 474619612 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 750 THIRD AVENUE STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 212-847-9841 MAIL ADDRESS: STREET 1: 750 THIRD AVENUE STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 3 1 a3.xml 3 X0206 3 2020-01-01 0 0001722964 Y-mAbs Therapeutics, Inc. YMAB 0001799303 Herman Philip Karl C/O Y-MABS THERAPEUTICS, INC. 230 PARK AVENUE, SUITE 3350 NEW YORK NY 10169 0 1 0 0 Sr. VP and CCO Employee Stock Option (right to buy) 13.11 2028-10-07 Common Stock 20000 D Employee Stock Option (right to buy) 21.45 2029-06-12 Common Stock 20000 D Employee Stock Option (right to buy) 33.74 2029-12-10 Common Stock 20000 D The stock option vested and became exercisable as to 25% of the shares subject to the option on 10/07/2019 and thereafter vests and becomes exercisable by 1/48th in equal monthly instalments, subject to continued employment of the Reporting Person at such times. The stock option vests and becomes exercisable as to 25% of the shares subject to the option on 6/12/2020 and thereafter vests and becomes exercisable by 1/48th in equal monthly instalments, subject to continued employment of the Reporting Person at such times. The stock option vests and becomes exercisable as to 25% of the shares subject to the option on 12/10/2020 and thereafter vests and becomes exercisable by 1/48th in equal monthly instalments, subject to continued employment of the Reporting Person at such times. s/s Philip Karl Herman 2020-01-09